MTFR1

MTFR1 is a nuclear-encoded mitochondrial inner-membrane protein that promotes mitochondrial fission and is essential for mitochondrial respiration and cellular redox homeostasis. Its pro-fission activity maps to a sequence-specific domain spanning residues 182–309; overexpression drives a network-to-spheroid mitochondrial transition, while loss of function severely impairs O₂ consumption, ATP synthesis, and antioxidant defense in vivo (PMID:15389597, PMID:20568109, PMID:17709566). NEK1-mediated phosphorylation at serine 119 under glucose deprivation switches MTFR1 from a fission-promoting to a fusion-promoting factor, sustaining oxidative phosphorylation during metabolic stress (PMID:40121946). MTFR1 expression is tightly regulated by multiple miRNAs—including miR-324-5p, miR-29c-3p, miR-194-5p, and miR-142—that modulate its levels to control mitochondrial dynamics, apoptosis, and metabolic reprogramming in cardiomyocytes, immune cells, and cancer cells (PMID:26633713, PMID:34926459, PMID:35107755, PMID:40334625).

1. 2004 High

   The first mechanistic question—where MTFR1 localizes and what it does to mitochondrial morphology—was resolved by showing it is an inner-membrane protein whose residues 182–309 are both necessary and sufficient for driving mitochondrial fission.

   Evidence Confocal/immuno-EM localization, domain deletion constructs, and MitoTracker labeling in multiple cell lines

   PMID:15389597

   Open questions at the time

   • No enzymatic activity identified for the 182–309 domain
   • Mechanism by which the poly-proline region promotes fission is unknown
   • No binding partners on the mitochondrial membrane identified
2. 2007 High

   Using a gene-trap knockout mouse, MTFR1 was established as necessary for antioxidant defense in vivo, linking its loss to downregulation of ROS-scavenging enzymes and oxidative DNA damage in the testis.

   Evidence Mtfr1-knockout mouse, real-time PCR, in situ hybridization, oxidative DNA damage assays in testes

   PMID:17709566

   Open questions at the time

   • Whether the antioxidant phenotype is a direct or indirect consequence of mitochondrial dysfunction is unresolved
   • Phenotype characterized only in testis
3. 2010 High

   The requirement of MTFR1 for mitochondrial respiration was directly demonstrated: knockdown and knockout each severely reduced O₂ consumption and ATP synthesis, establishing MTFR1 as a functional regulator of oxidative phosphorylation, not merely a morphology factor.

   Evidence siRNA knockdown in germ cells plus Mtfr1-knockout mouse testes with direct O₂ consumption and ATP assays

   PMID:20568109

   Open questions at the time

   • Whether MTFR1 acts on a specific respiratory complex or indirectly through membrane remodeling is unknown
   • Paralog Dufd1 was identified but its functional redundancy was not tested
4. 2015 High

   MTFR1 was placed within a defined signaling axis in cardiomyocytes: NFAT4 transcriptionally represses miR-324-5p, which directly targets MTFR1 mRNA, thereby controlling mitochondrial fission and apoptosis during myocardial ischemia.

   Evidence Luciferase reporter assay confirming MTFR1 as miR-324-5p target, siRNA knockdown, NFAT4 knockdown, in vivo myocardial infarction model

   PMID:26633713

   Open questions at the time

   • Whether MTFR1 is the sole effector of miR-324-5p in cardiomyocyte apoptosis is unclear
   • No structural basis for how fission leads to apoptosis commitment
5. 2019 Medium

   The miR-324-5p/MTFR1 axis was extended to endothelial progenitor cells, where miR-324-5p-mediated suppression of MTFR1 preserves membrane potential and protects against oxidative stress-induced apoptosis, generalizing the regulatory mechanism beyond cardiomyocytes.

   Evidence miR-324-5p mimic transfection, western blot, mitochondrial morphology and membrane potential assays in endothelial progenitor cells

   PMID:31066044

   Open questions at the time

   • No independent luciferase reporter validation in this study
   • Single cell type and single lab
6. 2021 Medium

   MTFR1 was linked to metabolic reprogramming in cancer: it promotes glycolysis and tumor growth through AMPK/mTOR signaling in lung adenocarcinoma, and is directly repressed by miR-29c-3p, revealing an additional miRNA layer of control.

   Evidence Dual-luciferase reporter, siRNA/overexpression, AMPK/mTOR western blots, xenograft model

   PMID:34926459

   Open questions at the time

   • Whether MTFR1 directly activates AMPK or alters its activity indirectly through mitochondrial dysfunction is unresolved
   • Single cancer type
7. 2022 Medium

   A competing endogenous RNA mechanism was established: lncRNA SNHG1 sponges miR-194-5p to de-repress MTFR1, promoting EMT in tongue squamous cell carcinoma and adding a lncRNA regulatory layer.

   Evidence Luciferase reporter, RNA pull-down, siRNA knockdown, Transwell and western blot for EMT markers

   PMID:35107755

   Open questions at the time

   • Whether MTFR1 directly drives EMT or acts through mitochondrial fragmentation-dependent ROS is unknown
   • Single cancer type, single lab
8. 2025 Medium

   Post-translational regulation of MTFR1 was uncovered: NEK1 phosphorylates MTFR1 at Ser119 under glucose deprivation, converting it from a fission promoter to a fusion promoter and thereby sustaining oxidative phosphorylation and cancer cell survival during metabolic stress.

   Evidence Mass spectrometry for interaction and phosphosite, co-immunoprecipitation, MitoTracker/JC-1/Seahorse assays in colon cancer cells

   PMID:40121946

   Open questions at the time

   • Structural basis for how a single phosphorylation reverses fission to fusion is unknown
   • Not independently confirmed outside colon cancer cells
   • No in vivo validation of the phospho-switch
9. 2025 Medium

   Consolidating the miRNA regulatory theme, miR-142 was shown to restrain MTFR1 in CD4⁺ T cells; loss of miR-142 leads to MTFR1 overexpression, impaired mitochondrial function, metabolic shift toward glycolysis, and reduced T cell fitness, extending MTFR1's role to adaptive immunity.

   Evidence Luciferase reporter, miR-142−/− mouse model, Seahorse, flow cytometry, single-cell sequencing, electron microscopy

   PMID:40334625

   Open questions at the time

   • Whether MTFR1 is the dominant miR-142 target responsible for the T cell metabolic phenotype is not excluded
   • Human T cell relevance not tested
10. 2025 Medium

    MTFR1 was connected to NF-κB signaling in triple-negative breast cancer, where its knockdown suppresses proliferation, migration, invasion, and NF-κB pathway activation, broadening its oncogenic relevance.

    Evidence siRNA knockdown, RNA-seq, western blot for NF-κB, xenograft model

    PMID:41222164

    Open questions at the time

    • Whether NF-κB activation is a direct consequence of MTFR1-driven mitochondrial fission or an indirect effect is unclear
    • Single cancer subtype

• Key unresolved questions include the biochemical activity of MTFR1 (no enzymatic function identified), the structural mechanism by which Ser119 phosphorylation reverses its fission/fusion role, and whether its pro-fission and pro-respiration functions are mechanistically separable.
• No enzymatic or structural characterization of MTFR1
• Fission-promoting versus respiration-promoting functions have not been dissected
• No reconstituted in vitro system for MTFR1-mediated fission